GLOW Blend (GHK-Cu, BPC-157, TB-500) 70mg

The GLOW Blend combines three synthetic peptides — GHK-Cu, BPC-157, and Thymosin Beta 4 (TB-500) — into a single lyophilized formulation supplied for in vitro laboratory research. Each component is studied for a distinct cell signaling mechanism, allowing researchers to examine multiple pathways within a single reagent batch.

GHK-Cu Cell Signaling Research

In vitro studies using cultured fibroblasts found that the GHK-Cu tripeptide-copper complex stimulated collagen synthesis within this cell-based system, with the effect observed across a range of peptide concentrations.¹

BPC-157 Structural Considerations

BPC-157 is a synthetic pentadecapeptide originally derived from a protein found in human gastric juice. Its unusually high proline content, roughly a quarter of its fifteen residues, is understood in peptide chemistry to impose conformational rigidity, a structural feature researchers have linked to the peptide's reported resistance to enzymatic degradation in laboratory assay systems.

Thymosin Beta 4 (TB-500) Cytoskeletal Research

Thymosin Beta 4 is part of the beta-thymosin family of low molecular weight acidic peptides, found in nearly all cell types.

It is studied for its role in cell motility and differentiation, forming a 1:1 complex with monomeric actin (G-actin) to act as an actin buffer that inhibits filament polymerization, relevant to laboratory research on cell migration and differentiation pathways.²

Combined Research Applications

This three-peptide formulation is studied for research into matrix-related signaling and cell-level tissue models across multiple mechanisms within a single controlled research platform.

Combined use of these peptides remains an area of exploratory laboratory research, and available data on multi-peptide interaction effects is preliminary and not considered conclusive.

Analytical Verification for Blended Products

For a three-component blend combining peptides of substantially different sizes, from GHK-Cu's three residues to TB-500's forty-three, analytical verification is understood to require confirmation of each component's individual identity and purity, along with the ratio between them.

Researchers reviewing documentation for this blend are encouraged to look for HPLC or mass spectrometry data resolving all three components as separate peaks.

Storage and Handling in the Laboratory Setting

Given the differing degradation sensitivities of a copper-chelated tripeptide, a proline-rich pentadecapeptide, and a larger methionine-containing protein, the lyophilized blend is stored under sub-zero freezer conditions to preserve all three components' integrity prior to use.

Important Notice

The GLOW Blend is intended exclusively for in vitro laboratory research and is not intended for human consumption, diagnostic use, or therapeutic use. Any application outside of controlled laboratory research is strictly prohibited. These findings do not establish safety, efficacy, or suitability for any human application, and this product has not been evaluated by the FDA or any regulatory agency.

Product Information

The GLOW Blend is supplied as a 70mg lyophilized white powder per vial, consisting of 50mg GHK-Cu, 10mg BPC-157, and 10mg Thymosin Beta 4 (TB-500), intended strictly for in vitro laboratory research.

References

1. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex GHK-Cu. FEBS Lett. 1988;238(2):343-346.
2. Huff T, Müller CS, Otto AM, Netzker R, Hannappel E. Beta-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol. 2001 Mar;33(3):205-20.